Karius Inc. has been awarded a contract from the Division of Research, Innovation, and Ventures (DRIVe), under the Biomedical Advanced Research and Development Authority (BARDA), valued at more than $600,000, that enables Karius to extend its current DNA pathogen detection capabilities to include RNA pathogen detection in a variety of human samples.
“We are delighted to partner with BARDA DRIVe in developing highly scalable tests that can rapidly identify any type of pathogen anywhere in